Share and Follow
Be the first to know
Get browser notifications for breaking news, live events, and exclusive reporting.
The FDA issued a new warning about some of the popular diabetes drugs being used for weight loss after the agency “received adverse event reports after patients used compounded semaglutide.” That’s the generic name for medications like Ozempic and Wegovy. New York endocrinologist Dr. Florence Comite joins CBS News to discuss the risks of taking off-brand versions.
Read Related Also: Two quiet ‘movers and shakers’ explain how to get elected officials to hear your concerns
Be the first to know
Get browser notifications for breaking news, live events, and exclusive reporting.